IP Verse

Ascensia Diabetes Care competitive analysis

Latest patents of Ascensia Diabetes Care opposed by its competitors

Explore Ascensia Diabetes Care's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Aug 27, 2026
Patent NumberPublication DateTitleTotal Oppositions
EP2109394
May 23, 2018Analyte-Testing Device2
EP1447665
Jun 29, 2016Method For Reducing Effect Of Hematocrit On Measurement Of An Analyte In Whole Blood, And Test Kit And Test Article Useful In The Method1
EP1733043
Jun 1, 2016Method And Apparatus For Implementing Threshold Based Correction Functions For Biosensors1
EP2134251
Aug 13, 2014Meter Adapted To Simultaneously Display The Number Of High, Low And Total Test Results2

Latest PTAB cases involving Ascensia Diabetes Care

Discover the latest PTAB cases involving Ascensia Diabetes Care, highlighting their recent legal challenges and patent disputes.

Peer Comparison New

IP litigation analysis comparing Ascensia Diabetes Care with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Aug 27, 2026
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases Faced
ASCENSIA DIABETES CARE - 6 - -
ABBOTT DIABETES CARE INC.2738179
DOWNING INTELLECTUAL2 - - -
ROCHE253422